Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q15366934> ?p ?o }
Showing triples 1 to 47 of
47
with 100 triples per page.
- Q15366934 subject Q7204516.
- Q15366934 subject Q8420862.
- Q15366934 subject Q8798541.
- Q15366934 abstract "Carfilzomib (marketed under the trade name Kyprolis, Onyx Pharmaceuticals, Inc.) is an anti-cancer drug acting as a selective proteasome inhibitor. Chemically, it is a tetrapeptide epoxyketone and an analog of epoxomicin.The U.S. Food and Drug Administration (FDA) approved it on 20 July 2012 for use in patients with multiple myeloma who have received at least two prior therapies, including treatment with bortezomib and an immunomodulatory therapy and have demonstrated disease progression on or within 60 days of completion of the last therapy. Approval is based on response rate. Clinical benefit, such as improvement in survival or symptoms, has not been verified.The abbreviation CFZ is common for referring to carfilzomib, but abbreviating drug names is not best practice in medicine.".
- Q15366934 atcPrefix "L01".
- Q15366934 atcSuffix "XX45".
- Q15366934 casNumber "868540-17-4".
- Q15366934 iupacName "(S)-4-Methyl-N-((S)-1-(((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamide".
- Q15366934 pubchem "11556711".
- Q15366934 thumbnail Carfilzomib.svg?width=300.
- Q15366934 wikiPageWikiLink Q14599311.
- Q15366934 wikiPageWikiLink Q17005771.
- Q15366934 wikiPageWikiLink Q204711.
- Q15366934 wikiPageWikiLink Q30612.
- Q15366934 wikiPageWikiLink Q309110.
- Q15366934 wikiPageWikiLink Q383836.
- Q15366934 wikiPageWikiLink Q419319.
- Q15366934 wikiPageWikiLink Q425681.
- Q15366934 wikiPageWikiLink Q466892.
- Q15366934 wikiPageWikiLink Q467635.
- Q15366934 wikiPageWikiLink Q485014.
- Q15366934 wikiPageWikiLink Q49112.
- Q15366934 wikiPageWikiLink Q5383826.
- Q15366934 wikiPageWikiLink Q5425270.
- Q15366934 wikiPageWikiLink Q585285.
- Q15366934 wikiPageWikiLink Q7095196.
- Q15366934 wikiPageWikiLink Q7180990.
- Q15366934 wikiPageWikiLink Q7204516.
- Q15366934 wikiPageWikiLink Q7251235.
- Q15366934 wikiPageWikiLink Q7251535.
- Q15366934 wikiPageWikiLink Q7706647.
- Q15366934 wikiPageWikiLink Q830382.
- Q15366934 wikiPageWikiLink Q8420862.
- Q15366934 wikiPageWikiLink Q8798541.
- Q15366934 atcPrefix "L01".
- Q15366934 atcSuffix "XX45".
- Q15366934 casNumber "868540".
- Q15366934 iupacName "-4".
- Q15366934 pubchem "11556711".
- Q15366934 type ChemicalSubstance.
- Q15366934 type Drug.
- Q15366934 type ChemicalObject.
- Q15366934 type Thing.
- Q15366934 type Q8386.
- Q15366934 comment "Carfilzomib (marketed under the trade name Kyprolis, Onyx Pharmaceuticals, Inc.) is an anti-cancer drug acting as a selective proteasome inhibitor. Chemically, it is a tetrapeptide epoxyketone and an analog of epoxomicin.The U.S.".
- Q15366934 label "Carfilzomib".
- Q15366934 depiction Carfilzomib.svg.